The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 15,263 | 370,000 | SH | OTR | 370,000 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 3,900 | 550,000 | SH | OTR | 550,000 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 25,602 | 831,495 | SH | OTR | 831,495 | 0 | 0 | ||
AGENUS INC | COM NEW | 00847G705 | 16,000 | 4,000,000 | SH | OTR | 4,000,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 54,979 | 675,000 | SH | OTR | 675,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 29,470 | 7,000,000 | SH | OTR | 7,000,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 32,829 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 19,175 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 35,735 | 2,084,883 | SH | OTR | 2,084,883 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 44,871 | 170,926 | SH | OTR | 170,926 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 7,083 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
ARYA SCIENCES ACQUISITION CO | COM CL A | G3166W106 | 6,270 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 30,767 | 2,202,333 | SH | OTR | 2,202,333 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 31,565 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 319,148 | 1,114,188 | SH | OTR | 1,114,188 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 6,753 | 2,975,000 | SH | OTR | 2,975,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 19,020 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 60,909 | 2,014,858 | SH | OTR | 2,014,858 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 16,979 | 1,566,361 | SH | OTR | 1,566,361 | 0 | 0 | ||
CELLECTAR BIOSCIENCES INC | COM PAR | 15117F500 | 1,141 | 920,000 | SH | OTR | 920,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 14,830 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
COMPUGEN LTD | ORD | M25722105 | 38,735 | 2,383,673 | SH | OTR | 2,383,673 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 28,960 | 4,000,000 | SH | OTR | 4,000,000 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 13,035 | 7,534,598 | SH | OTR | 7,534,598 | 0 | 0 | ||
DIREXION SHS ETF TR | DAILY S&P BIOTEC | 25460G716 | 14,920 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 36,241 | 975,000 | SH | OTR | 975,000 | 0 | 0 | ||
FS DEV CORP | COM CL A | 303020101 | 7,839 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 5,598 | 705,882 | SH | OTR | 705,882 | 0 | 0 | ||
GENOCEA BIOSCIENCES INC | COM NEW | 372427401 | 2,598 | 1,134,453 | SH | OTR | 1,134,453 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 13,785 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 31,799 | 2,562,358 | SH | OTR | 2,562,358 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 4,400 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 27,667 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 382,635 | 4,500,000 | SH | OTR | 4,500,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 48,757 | 1,176,000 | SH | OTR | 1,176,000 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 107,192 | 4,345,016 | SH | OTR | 4,345,016 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 24,327 | 6,205,882 | SH | OTR | 6,205,882 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 4,452 | 290,577 | SH | OTR | 290,577 | 0 | 0 | ||
KODIAK SCIENCES INC | COM | 50015M109 | 16,291 | 275,138 | SH | OTR | 275,138 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 32,181 | 1,050,289 | SH | OTR | 1,050,289 | 0 | 0 | ||
LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 3,590 | 890,700 | SH | OTR | 890,700 | 0 | 0 | ||
LIFESCI ACQUISITION CORP | UNIT 03/31/2025 | 53228P208 | 4,080 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 123,360 | 9,600,000 | SH | OTR | 9,600,000 | 0 | 0 | ||
MATINAS BIOPHARMA HLDGS INC | COM | 576810105 | 8,793 | 11,478,634 | SH | OTR | 11,478,634 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 9,089 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 10,558 | 4,029,649 | SH | OTR | 4,029,649 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 13,009 | 1,777,194 | SH | OTR | 1,777,194 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 293,171 | 1,765,560 | SH | OTR | 1,765,560 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 6,109 | 317,000 | SH | OTR | 317,000 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 18,013 | 1,501,058 | SH | OTR | 1,501,058 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 47,282 | 1,354,392 | SH | OTR | 1,354,392 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 69,931 | 5,207,086 | SH | OTR | 5,207,086 | 0 | 0 | ||
PANACEA ACQUISITION CORP | CL A | 698102100 | 8,958 | 800,000 | SH | OTR | 800,000 | 0 | 0 | ||
PANDION THERAPEUTICS INC | COM | 698340106 | 24,152 | 2,107,513 | SH | OTR | 2,107,513 | 0 | 0 | ||
PASSAGE BIO INC | COM | 702712100 | 25,280 | 1,928,315 | SH | OTR | 1,928,315 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 80,522 | 2,268,236 | SH | OTR | 2,268,236 | 0 | 0 | ||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 11,097 | 1,251,055 | SH | OTR | 1,251,055 | 0 | 0 | ||
PREVAIL THERAPEUTICS INC | COM | 74140Y101 | 11,433 | 1,123,105 | SH | OTR | 1,123,105 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 3,521 | 209,227 | SH | OTR | 209,227 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 53,321 | 1,251,959 | SH | OTR | 1,251,959 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 11,286 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 115,162 | 3,309,264 | SH | OTR | 3,309,264 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 33,514 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 66,865 | 1,094,000 | SH | OTR | 1,094,000 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 78,276 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 8,144 | 3,284,072 | SH | OTR | 3,284,072 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 3,110 | 1,531,872 | SH | OTR | 1,531,872 | 0 | 0 | ||
SPECTRUM PHARMACEUTICALS INC | COM | 84763A108 | 13,600 | 3,333,333 | SH | OTR | 3,333,333 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 98,958 | 2,075,905 | SH | OTR | 2,075,905 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 33,768 | 2,287,782 | SH | OTR | 2,287,782 | 0 | 0 | ||
THERAPEUTICS ACQUISITION COR | COM CL A | 88339T103 | 21,570 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 28,190 | 765,400 | SH | OTR | 765,400 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 6,642 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 489 | 27,300 | SH | OTR | 27,300 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 7,686 | 165,000 | SH | OTR | 165,000 | 0 | 0 |